ATS: Day, night staffing linked to mortality in ICU

Share this article:
ATS: Day, Night Staffing Linked to Mortality in ICU
ATS: Day, Night Staffing Linked to Mortality in ICU

(HealthDay News) -- For patients admitted to the intensive care unit (ICU), nighttime intensivist staffing is associated with reduced in-hospital mortality in ICUs that have low-intensity daytime staffing, according to a study published online May 21 in the New England Journal of Medicine to coincide with presentation at the annual meeting of the American Thoracic Society, held from May 18 to 23 in San Francisco.

To investigate whether nighttime intensivist staffing correlates with the quality of ICU care, David J. Wallace, M.D., M.P.H., from the University of Pittsburgh School of Medicine, and colleagues conducted a retrospective cohort study of data from 65,752 patients admitted to 49 ICUs in 25 hospitals participating in the Acute Physiology and Chronic Health Evaluation (APACHE) clinical information system from 2009 through 2010. A confirmatory analysis was conducted in a second population-based cohort of hospitals.

Based on data from the APACHE database, in ICUs with low-intensity daytime staffing, the researchers found that nighttime intensivist staffing correlated with a decrease in the risk-adjusted in-hospital mortality (adjusted odds ratio [OR], 0.62; P = 0.04). For ICUs with high-intensity daytime staffing, nighttime staffing offered no additional benefit to the risk-adjusted in-hospital mortality (OR, 1.08; P = 0.78). A similar association was seen between daytime staffing, nighttime staffing, and in-hospital mortality in the verification cohort, although the interaction between nighttime and daytime staffing was not significant (P = 0.18).

"Our multicenter evaluation showed that nighttime intensivist staffing was associated with reduced in-hospital mortality among patients admitted to ICUs with low-intensity daytime staffing, but with no incremental benefit among patients admitted to ICUs with high-intensity daytime staffing," the authors write.

Abstract
Full Text
Editorial
More Information

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.
close

Next Article in Daily Oncology News

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

70-Gene signature not likely to be cost-effective for breast cancer

70-Gene signature not likely to be cost-effective for ...

Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.

Many clinicians feel mobile apps can improve patient outcomes

Many clinicians feel mobile apps can improve patient ...

Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.

Overdetection of PSA recurrence after radical prostatectomy more likely in older patients

Overdetection of PSA recurrence after radical prostatectomy more ...

For some men, prostate cancer recurrence may be overdetected, especially in those aged over 70.